Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.07.22.740070

Sequence-based modeling of plant epigenomes reveals cell-type-specific cis-regulatory grammar

Abstract

How cis-regulatory sequences and their genetic variation govern chromatin accessibility and gene expression to establish plant cell identities remains incompletely understood, despite their fundamental roles in development, environmental responses, and phenotypic diversity. Here we present PEAgent, a framework for training, evaluating and interpreting deep-learning models that predict single-cell chromatin accessibility directly from DNA sequence, packaged in an interactive web portal and toolkit. Models were trained on single-cell chromatin-accessibility atlases of soybean, maize and rice, together spanning over 355,000 cells and 320 cell types and [~]150 million years of evolution. We unraveled a lexicon of 243 cell-type-resolved regulatory patterns, half of them composite, with TCP and bHLH showing the greatest influence and strongest conservation across species. Co-occurrence and in silico synergy analyses, explicitly modeling motif orientation and spacing, revealed two distinct cooperative modes acting at short and nucleosome-scale distances. We further showed that model predictions distinguish grass-conserved from rice-specific regulatory sequences far more accurately than sequence conservation scores alone, and validated the models predicted variant effects against cell-type-level chromatin accessible QTLs. PEAgent provides a foundational resource for decoding cell-type-specific plant cis-regulatory logic and interpreting noncoding variation in plants. HighlightsO_LIPEAgent predicts single-cell chromatin accessibility directly from DNA sequence in soybean, rice and maize. C_LIO_LINearly half of cell-type-resolved patterns are composite, with TCP and bHLH motifs most influential and conserved across species. C_LIO_LICo-occurrence and synergy analysis reveals distinct cooperative grammar at short and nucleosome-scale distances. C_LIO_LIPEAgent distinguishes grass-conserved from lineage-specific regulatory sequences better than sequence conservation scores alone. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yao, J., Li, J., Zhang, X., Li, X., Marand, A. P., Pickering, E., Schmitz, R. J.. 2026-07-22. Sequence-based modeling of plant epigenomes reveals cell-type-specific cis-regulatory grammar. https://doi.org/10.64898/2026.07.22.740070

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗